Eribulin in BRAF V600E-mutant metastatic colorectal cancer: case series and potential rationale

Ann Oncol. 2018 May 1;29(5):1330-1331. doi: 10.1093/annonc/mdy107.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / metabolism
  • Aged
  • CA-19-9 Antigen / blood
  • Colorectal Neoplasms / diagnostic imaging
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Disease Progression
  • Fatal Outcome
  • Female
  • Furans / pharmacology
  • Furans / therapeutic use*
  • Humans
  • Ketones / pharmacology
  • Ketones / therapeutic use*
  • Male
  • Middle Aged
  • Mitosis / drug effects
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Burden / drug effects

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • CA-19-9 Antigen
  • Furans
  • Ketones
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • eribulin